Sildenafil Citrate for Women
	 Volume 1 - Issue 5
		
		Mohamed Nabih EL Gharib*
		
		
		
		      - 
                
				Author Information
Open or Close
                
				
				
		- Department of Obstetrics & Gynecology, Tanta University, Egypt
 *Corresponding author:  Mohamed Nabih EL-Gharib, Professor of Obstetrics & Gynecology, Faculty of Medicine, Tanta University,
Egypt
				 
 
 
 
 
			
			
			
				Received: October 03, 2018;   Published: October 09, 2018
             
      DOI:  10.32474/OAJRSD.2018.01.000124
			 
			   		
			   
			    Full Text
			   Full Text
			   
			   
			    PDF
			   PDF
			   
			   
				To view the Full Article    Peer-reviewed Article PDF
		
		Abstract
  Sildenafil citrate (SC) is a medicinal drug used to treat male
erectile dysfunction and pulmonary hypertension. Sildenafil is a
selective and potent competitive inhibitor of the cyclic guanosine
monophosphate (cGMP) -specific phosphodiesterase-type 5
(PDE-5) enzymes, which, by preventing the breakdown of cGMP,
potentiate the action of NO in tissues that contain PDE-5. Thus,
increasing vasodilatation and potentiating the effects of nitrous
oxide (NO) on the vascular smooth muscle [1-2]. SC increases
uterine blood flow and potentiates estrogen-induced vasodilatation
[3]. Sildenafil citrate is metabolized is in the liver by cytochrome
P450, the metabolites are: N-desmethylsildenafil (about 50%
potency for PDE5). The biological half-life is from 3 to 4 hours, it is
excreted in feces and in urine [4].
        
       
		
				    
            
Short Communication|
References|